Figure legends
Figure 1 Prevalence of IDH1/IDH2 mutations in 28,868
patients with pan-cancer.
Figure 2 Top 20 significantly mutated genes in IDH1/2mutated patients of biliary tract cancer (A), liver cancer (B), lung
cancer (C), colorectal cancer (D) and gastric cancer (E). Genes were
ranked by mutation frequencies (right panel). Age and gender are
annotated in the top panel. Tumor mutational load among IDH1/2mutated pan-cancers (F) and in biliary tract cancer (G).